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Palisade endings are nerve specializations found in the extraocular muscles (EOMs) of mammals, including primates. They have long
been postulated to be proprioceptors. It was recently demonstrated that palisade endings are cholinergic and that in monkeys they
originate from the EOMmotor nuclei. Nevertheless, there is considerable difference of opinion concerning the nature of palisade ending
function.
Palisade endings in EOMs were examined in cats to test whether they display motor or sensory characteristics. We injected an
anterograde tracer into the oculomotor or abducens nuclei and combined tracer visualization with immunohistochemistry and
-bungarotoxin staining. Employing immunohistochemistry, we performed molecular analyses of palisade endings and trigeminal
ganglia to determine whether cat palisade endings are a cholinergic trigeminal projection.
We confirmed that palisade endings are cholinergic and showed, for the first time, that they, like extraocular motoneurons, are also
immunoreactive for calcitonin gene-related peptide. Following tracer injection into the EOMnuclei, we observed tracer-positive palisade
endings that exhibited choline acetyl transferase immunoreactivity. The tracer-positive nerve fibers supplying palisade endings also
established motor terminals along the muscle fibers, as demonstrated by -bungarotoxin. Neither the trigeminal ganglion nor the
ophthalmic branch of the trigeminal nerve contained cholinergic elements.
This study confirms that palisade endings originate in theEOMmotornuclei and further indicates that they are extensions of the axons
supplying the muscle fiber related to the palisade. The present work excludes the possibility that they receive cholinergic trigeminal
projections. These findings call into doubt the proposed proprioceptive function of palisade endings.
Introduction
To localize the position of objects in the surrounding visual space,
the CNS needs visual information from the retina and additional
information about eye position in the orbit. It is believed that
such nonvisual eye position information comes from sense or-
gans (proprioceptors) within the extraocular muscles (EOMs).
However, in the EOMs of mammals, classical proprioceptors
(muscle spindles and Golgi tendon organs) are absent in most
species except even-toed ungulates (Maier et al., 1974). The rea-
son for these interspecies variations is unclear. Another structure,
unique to EOMs, has been found in all mammalian species thus
far investigated—the palisade ending, also called the innervated
myotendinous cylinder (Dogiel, 1906; Ruskell, 1978; Alvarado-
Mallart and Pinc¸on-Raymond, 1979). Palisade endings are en-
capsulated nervous end organs and arise from axons coming
from the muscle belly and entering the proximal and distal ten-
dons. The axons turn back 180° within the tendon to terminate in
a cuff of nerve terminals around the tip of a single muscle fiber.
The muscle fibers associated with palisade endings are the mul-
tiply innervatedmuscle fibers (MIFs) of the global layer of EOMs.
These possess several en grappe nerve endings along their length
(Ruskell, 1978; Alvarado-Mallart and Pinc¸on-Raymond, 1979).
The functional significance of palisade endings is still a matter
of discussion. It is not clear whether they are sensory (Ruskell,
1978; Alvarado-Mallart and Pinc¸on-Raymond, 1979; Billig et al.,
1997; Bu¨ttner-Ennever et al., 2003), motor (Sas and Scha´b, 1952;
Konakci et al., 2005a; Blumer et al., 2009), or both (Lukas et al.,
2000). Arguments for a sensory role arise from their peculiar
location at the muscle–tendon transition (Ruskell, 1978;
Alvarado-Mallart and Pinc¸on-Raymond, 1979), their similarities
to Golgi tendon organs (Zelena´ and Soukup, 1977), and a report
in cats of anterograde labeling from the sensory trigeminal gan-
glion (Billig et al., 1997). Evidence that palisade endings are mo-
tor is also available in the literature. Palisade endings degenerate
after lesions of the oculomotor nuclei and have a cholinergic
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phenotype. Furthermore, in 30% of the cases, axons supplying
monkey palisade endings establish additional motor terminals
along the muscle fibers (Sas and Scha´b, 1952; Konakci et al.,
2005a; Konakci et al., 2005b; Blumer et al.,
2009). Recently, palisade endings inmon-
key have been anterogradely labeled after
tracer injection into the EOM motor nu-
clei (Lienbacher et al., 2011a; Zimmer-
mann et al., 2011). In a subsequent report,
Lienbacher et al. (2011b) suggested that
despite this origin, palisade endings are
sensory and arise from sensory-like neu-
rons detected around the periphery of the
oculomotor nucleus.
Here, we analyzed palisade endings in
cats to test whether these structures exhibit
motor as opposed to sensory features. First,
we examined the molecular characteristics
of palisade endings by use of calcitonin
gene-related peptide (CGRP) detection.
Second, we made central tracer injections
into EOMmotor nuclei and combined the
anterograde labeling of axons with choline
acetyl transferase immunohistochemistry
and-bungarotoxin staining. Third, we ex-
amined whether palisade endings receive
cholinergic trigeminal projections.
Materials andMethods
In the present study, four adult female cats
weighing between 2.0 and 2.5 kg were used for
central tracer injections. Surgical and handling
procedures for experiments followed the
guidelines of the National Institute of Health
(http:/oacu.od.nih.gov) and specific recom-
mendations for maintenance of higher mam-
mals during neuroscience experiments (NIH
publication no. 94-3207,1994) and were in ac-
cordance with national legislation for the use
and care of laboratory animals (R.D. 120/2005
BOE 252/34367-91,2005).
Tracer injection
In two cats (cat 1 and 2) the anterograde tracer,
biotinylated dextran amine (BDA), was in-
jected bilaterally into the oculomotor nuclei,
and in two other cats (cat 3 and 4) BDA was
injected bilaterally into the abducens nuclei.
Surgical procedure
Cats were anesthetized (sodium pentobarbital,
35 mg/kg, i.p.) and prepared for BDA injec-
tion. Bipolar electrodes were implanted stereo-
taxically in the abducens or the oculomotor
nerve at its exit from the brainstem to identify
the corresponding motor nucleus by locating
the antidromically evoked field potential be-
fore injection. Electrical stimulation consisted of square wave single
pulses of 50s duration and50A intensity. BDAwas electrophoreti-
cally injected into either the abducens or the oculomotor nuclei at sites
Figure 1. Three-dimensional projections of stacks of CLSM images showing triple fluorescence staining of palisade endings in the
muscle–tendon transition ofwhole-mount preparations.A–H, All palisade endings exhibit a characteristic shape; nerve fibers extending
alongthemusclefibersreachontothetendon,wheretheyturnback180°toterminateinarborizationsatthetipofasinglemusclefiber.The
tendon is not visualized and continues to the right of the muscle fibers. A–C, Palisade endings are supplied by a bundle of axons. D–H,
Palisade endings are supplied by a single axon.A–C, Staining of amedial rectusmusclewith anti-neurofilament (red), anti-ChAT (green),
andphalloidin (blue).A,B, Palisadeendings showingneurofilament immunoreactivity (A) andChAT immunoreactivity (B).C, OverlayofA
andBappears inayellowmixedcolor showing thatall palisadeendingsexhibitneurofilament/ChAT immunoreactivity.D–F, Stainingofa
superior rectusmusclewith anti-ChAT (red), anti-CGRP (green), andphalloidin (blue).D,E, A palisadeendingexhibitingChAT immunore-
activity(D)andCGRPimmunoreactivity(E).F,OverlayofDandEshowingthepalisadeinayellowmixedcolor.G,Stainingofamedial rectus
muscle with anti-neurofilament (red), anti-synaptophysin (green), and phalloidin (blue). A nerve fiber forming a palisade ending estab-
lishes neuromuscular contacts (arrows) along themuscle fiber. Palisade nerve terminals and neuromuscular contacts are synaptophysin
immunoreactive. Neuromuscular contacts outside the palisade complex resemble en grappemotor terminals of the multiply innervated
muscle fiber,MIF.H, Stainingof anoblique inferiormusclewith anti-neurofilament (red),-bungarotoxin (green), andphalloidin (blue).
The nerve fiber supplying the palisade ending establishes-bungarotoxin-positivemotor contacts (arrows) along themuscle fiber. Note
thatunlikeotherterminalstheaxonsmakesonthefiber,palisadenerveterminals lack-bungarotoxinstaining. InadditiontotheMIFwith
a palisade ending, a secondMIF is labeled inG andH. Scale bars, 100m.
Table 1. List of antibodies and other markers, including their working dilution, used in this study
Primary antibodies (Millipore) Secondary antibodies (Invitrogen) Other markers (Sigma 1; Invitrogen 2)
Goat anti-choline acetyltransferase (1:100) Rabbit anti-goat Alexa Fluor 488 (1:500/1:300) Phalloidin Atto647 (1:100)1
Chicken anti-neurofilament (1:500/1:300) Donkey anti-goat Alexa Fluor 568 (1:500/1:300) -bungarotoxin rhodamine/Alexa Fluor 488 (1:500/1:300)1
Rabbit anti-CGRP (1:400/1:300) Goat anti-chicken Alexa Fluor 568 (1:500/1:300) Avidin Alexa Fluor 488 (1:250/1:150)2
Mouse anti-synaptophysin (1:500/1:200) Goat anti-rabbit Alexa Fluor 488 (1:500/1:300) Streptavidin Alexa Fluor 568 (1:500/1:300)2
Goat anti-mouse Alexa Fluor 488 (1:500/1:300) Streptavidin-HRP (1:1000/1:600)2
The first working dilution within the bracket is for the staining of sections of the muscle belly, the second working dilution is for staining of the whole mounts.
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where evoked potentials were recorded. Glass
micropipettes bevelled to a tip diameter of 15
m were filled with a solution of 10% BDA in
0.05 M Tris-HCl buffer (pH 7.4). Positive cur-
rent pulses of 7 A intensity were delivered at
50% duty cycle (7 s on, 7 s off) for 20 min at
three different rostrocaudal locations. Animals
weremonitored daily after surgery and postop-
erative care was provided using analgesics (pi-
razolone, 0.1 g/kg/d, i.m.) and antibiotics
(streptomycin and penicillin, 20,000 IU/kg/d,
i.m.) during the initial 3 days.
Following a survival time of 3 weeks, the an-
imals were deeply anesthetized with a terminal
dose of sodium pentobarbital. The ascending
aorta was cannulated and the circulatory sys-
tem was rinsed with Ringer solution, followed
by perfusion fixation with 4% paraformalde-
hyde in 0.1 M sodiumphosphate buffer, pH 7.4.
The brainstem, the trigeminal ganglia, includ-
ing the ophthalmic, maxillary, andmandibular
nerves, and the EOMs were removed. The tis-
sue was immersion fixed for 2 h in the above
fixative and then stored in buffer (4°C) before
processing.
The EOMs were cut transversally into two
pieces: one piece containing the muscle belly
and the second containing the distal tendon,
including the muscle–tendon transition. The
distal myotendons of the EOMs were cryopro-
tected and frozen as whole-mount prepara-
tions. The muscle bellies and the trigeminal
ganglia were also cryoprotected, frozen, and
cut 10 m thick with a microtome (CM1950,
Leica). The muscle bellies were cut lengthwise,
parallel to the orbital surface of the muscle,
and the trigeminal ganglia were cut roughly
in the frontal plane. Sections were mounted
onto glass slides (SuperFrost Ultra Plus, Fisher
Scientific). Brainstem coronal sections were cut
at 50mwith a vibratome (VT1000S, Leica) and
further processed, free-floating, for the detection
of the injection site.
EOM whole-mounts and tissue sections
were processed for fluorescence labeling, tracer
detection, or alternatively for combinations of
tracer detection and fluorescence labeling. In
particular, the nontracer labeled EOMs of the
oculomotor/abducens cases and the trigeminal
ganglia were used for fluorescence labeling. The brainstems and tracer
labeled EOMs (muscle bellies and musculotendinous transitions) were
used for single tracer detection or alternatively for tracer detection com-
bined with fluorescence labeling.
Immunofluorescence labeling
Sections of the trigeminal ganglionwere labeledwith antibodies against cho-
line acetyltransferase (ChAT) and neurofilament proteins or antibodies
against CGRP and neurofilaments. EOMwhole-mounts (distal EOMmyo-
tendons) from muscles that did not contain BDA-positive axons were la-
beled with four combinations of triple-fluorescent labeling: (1) antibodies
against ChAT and neurofilaments and with phalloidin (used as counter-
staining of the muscle fibers); (2) antibodies against ChAT and CGRP and
with phalloidin; (3) antibodies against neurofilaments and synapto-
physin and with phalloidin; and (4) antibody against neurofilaments
and-bungarotoxinandwithphalloidin.Thesourcesandworkingdilutions
of phalloidin,-bungarotoxin, primary antibodies, and secondary antibod-
ies are listed in Table 1.
Tissue was blocked for 2 h with 10% serum (according to the second-
ary antibodies) in sodium PBS containing Triton X-100 (PBS-T): 0.1%
Triton X-100 for trigeminal ganglion sections or 1% Triton X-100 for
EOM whole-mounts. Then, the tissue was incubated for 48 h with the
primary antibodies, rinsed thoroughly with PBS-T, and incubated with
one of the secondary antibodies for 2 h for sections and 24 h for whole
mounts. After another washing step, tissue was incubated with the other
secondary antibody and phalloidin overnight (staining combinations 1–3)
or with -bungarotoxin and phalloidin (staining combination 4). Finally,
the tissue was rinsed again and mounted in 60% glycerine (v/v) plus 40%
PBS.
For negative control experiments, primary antibodies were omitted
and secondary antibodies were used alone. In all cases, the omission of
the primary antibodies resulted in a complete lack of immunostaining.
Single-color and multicolor tracer detection
In single-color preparations the tracer was visualized using conventional
avidin–biotin procedures. Alternatively, in multicolor preparations
tracer visualization with fluorescent avidin/streptavidin was combined
with additional fluorescent staining of cellular markers.
Single-color detection. Sections of the brainstem and EOMmuscle bel-
lies, as well as muscle/tendon whole mounts, were blocked in 5% H2O2
and incubated with horseradish peroxidase-conjugated streptavidin
Figure 2. BDA tracer injections and labeling in the brainstem. The tracer was visualized with the DAB reaction and enhanced
with ammonium sulfate, and so it appears in black. A, B, Image of the injection site in the oculomotor nucleus (A) and in the
abducens nucleus (B). Scale bars, 1 mm. C, D, Rootlets of the oculomotor nerve (N III) (C) and the abducens nerve (N VI) (D) show
axons anterogradely labeled with BDA. Scale bars, 100m. E, F, Antidromic field potentials obtained after single pulse electrical
stimulation applied to the IIIrd (E) and VIth (F ) nerves, respectively. Arrowhead denotes the stimulus artifact produced by the
electrical stimulation to the corresponding nerve.
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(Dako) (2 h for sections and 48 h for whole mounts). Following several
washes in PBS, tissue was incubated in a freshly prepared solution con-
taining 3.3-diaminobenzidine tetrahydrochloride and 0.06% H2O2. In
the brainstem sections, ammonium sulfate was added to the incubation
medium to obtain an intensified black reaction product.
Multicolor detection. Sections of the EOM muscle bellies and EOM
whole mounts were used for triple-label analyses. Four different combi-
nations of triple-staining were performed on tissue from muscles that
contained BDA labeled axons: (1) streptavidin, anti-synaptophysin, and
phalloidin; (2) avidin, anti-ChAT, and phalloidin; (3) streptavidin, anti-
CGRP, and phalloidin; and (4) streptavidin, -bungarotoxin, and phal-
loidin. Staining combination 1 was used to label tracer-positive axons
and nerve terminals and combinations 2, 3, and 4 were used to test
whether tracer-positive axons were ChAT andCGRP immunoreactive or
to establish -bungarotoxin-positive motor terminals.
In staining combinations 1, 2 and 3, tissue
was blocked in 10% serum (according to the
secondary antibodies) and then incubated for
48 h with the primary antibodies. Following
rinsing in PBS-T, tissue was incubated with the
corresponding secondary antibodies for 2 h
(sections) or 24 h (whole-mounts). Then, tis-
sue was incubated for 2 h (sections) or 24 h
(whole-mounts) with streptavidin/avidin and
phalloidin. In staining combination 4, tissue
was incubated in a solution containing
-bungarotoxin (conjugated with Alexa Fluor
488), streptavidin (with Alexa Fluor 568), and
phalloidin (with Alexa Fluor 633) for 2 h (sec-
tions) or 24 h (whole-mounts).
Data analysis
DAB-labeled sections and whole mounts were
analyzed with a light microscope (Zeiss Axio-
scope) and images were taken with a Nikon
Eclipse 600 camera. Images of palisade endings
were recorded at different focal depths (1m),
and 3D projections were obtained using the
software Lucia G (Nikon, Du¨sseldorf).
Fluorescently labeled sections and whole
mounts were analyzed with a confocal laser
scanning microscope (CLSM; LSM 510, Carl
Zeiss Meditec). Series of virtual CLSM sec-
tions of 0.5 – 1 m thickness were cut
through the structures of interest. Each sec-
tion was photo-documented and 3D projec-
tions were formulated on a computer using
LSM Image Examiner software (Carl Zeiss
Meditec). Images were generated in three
different fluorescence channels with excita-
tion wavelengths of 488, 568, and 633 nm. In
some cases a transmission light image was
recorded instead of the image with 633 nm
excitation.
Results
Morphology of palisade endings
Palisade endings were analyzed in EOM
whole mounts of the distal muscle tendon
transition. Suchwhole-mount preparations
allow study of the overall morphology of
palisade endings. We observed palisade
endings in each EOM. All palisade endings
exhibited a typical structure; axonsoriginat-
ing from themuscle belly extended onto the
tendon, where they turned back 180° to ter-
minate in a cuff of terminals around the tip
of a single muscle fiber. Usually, palisade
Figure 3. Three-dimensional projections from stacks of CLSM images showing BDA tracer combinedwith fluorescence staining
of other cellular molecules. A–C, Tracer visualization with avidin (green) was combined with anti-ChAT labeling (red). A, Tracer-
positive axons at the entry site of the abducens nerve in the lateral rectusmuscle.B, The axons of this abducens nerve exhibit ChAT
immunoreactivity. C, Overlay of A and B in yellow mixed color showing that all tracer-positive axons also exhibit ChAT immuno-
reactivity, but other ChAT-positive axons contained no tracer. D–I, Triple fluorescence staining with streptavidin (green),
-bungarotoxin (red), and phalloidin (blue) of a medial rectus muscle. D, G, Tracer-positive axons establishing neuromuscular
contacts resembling en plaque motor terminals (D) and en grappe motor terminals (G). E, H, En plaque and en grappe motor
terminals, respectively, after -bungarotoxin labeling. F, I, Overlays in yellow mixed color confirming that tracer-positive en
plaque-like and en grape-like endings bind -bungarotoxin. Other motor terminals (arrows) lack tracer (I ). J–O, Triple fluores-
cence staining with streptavidin (red), anti-CGRP (green), and phalloidin (blue) J,M, Tracer-positive axons establishing en plaque
and en grappemotor terminals, respectively.K,N, Tracer-positive axons andmotor terminals exhibit CGRP immunoreactivity. The
arrows in J and K show the tracer (BDA)-positive axon (in J ), which also showed CGRP immunolabeling (in K ). L, O, Overlays in
yellowmixed color. En grappe endings are indicated by arrows (O). Scale bars, 50m.
Table 2. Percentage of tracer-positive axons in the extraocular muscles of cats 1, 2,
3, and 4
Oculomotor injections Abducens injections
EOM Cat 1a Cat 2a Cat 3a Cat 4a
SR le/rib 22/16 17/15 —/— —/—
IR le/rib 55/58 49/73 —/— —/—
LR le/rib —/— —/— 64/46 51/31
MR le/rib 47/53 47/36 —/— —/—
SO le/rib —/— —/— —/— —/—
IO le/rib 14/28 39/12 —/— —/—
LPS le/rib 10/6 5/6 —/— —/—
aPercentage of tracer-positive axons.
bAbbreviations indicate the followingmuscles: SR, Superior rectus; IR, inferior rectus; LR, lateral rectus; MR, medial
rectus; SO, superior oblique; IO, inferior oblique, LPS, levator palpebrae superioris. Left and right are indicated as le
and ri, respectively.
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endings were formedby single axons (Fig.
1D–H), but occasionally we also found
palisade endings that were supplied by
two or more nerve fibers (Fig. 1A–C).
When possible, nerve fibers supplying
palisade endings were traced back from
their terminal branches in the tendon to-
ward the muscle. We observed axons sup-
plying palisade endings that established
contacts along the muscle fibers (Fig.
1G,H). Such additional neuromuscular
contacts resembled en grappemotor end-
ings of MIF and were observed in 25% of
the palisade endings. In the remaining
cases it was not possible to evaluate whether
axons supplying palisades established addi-
tional neuromuscular contacts, either
because the axon-forming palisades inter-
mingled with other axons or because it
was not running alongside the muscle fi-
ber and approached the palisade laterally
(Fig. 1A–C).
Palisade endings exhibit ChAT/CGRP
immunoreactivity and are supplied by axons that establish
-bungarotoxin-positive contacts along the muscle fibers
To determine the molecular characteristics of palisade endings,
muscle/tendon whole mounts were triple fluorescent-stained
with different combination ofmarkers for cellularmolecules.We
used antibodies against ChAT, CGRP, synaptophysin, and neu-
rofilament as well as -bungarotoxin labeling. Phalloidin was
used to stain muscle fibers.
It was demonstrated that axons supplying palisade endings
exhibited ChAT/neurofilament immunoreactivity. In those cases
in which palisade endings were supplied by multiple axons, all
axons were ChAT/neurofilament positive (Fig. 1A–C). More-
over, all palisade endings exhibited CGRP immunoreactivity
(Fig. 1D–F), analogous to that observed in motor axons and en
plaque and en grappe motor endings (see below, next section,
fourth paragraph). Palisade nerve terminals were positive for
synaptophysin (amarker for all kinds of nerve synaptic terminals;
Fig. 1G) but lacked-bungarotoxin staining (the classicalmarker
formotor nerve terminals; Fig. 1H). Since-bungarotoxin labels
nicotinic acetylcholine receptors on the muscle fiber membrane,
this finding suggests that palisade nerve terminals established
contacts on the tendon and not on the muscle fibers. This is in
line with ultrastructural studies in which most palisade nerve
terminals were observed to contact the tendon, and palisade
nerve terminals contacting the muscle fiber were an exceptional
feature ( Alvarado-Mallart and Pinc¸on-Raymond, 1979; Konakci et
al., 2005a). On the other hand, additional neuromuscular contacts
along the muscle fibers made by the same axon that supplied the
palisade endings were positive for synaptophysin and
-bungarotoxin as well (Fig. 1G, 1H).
Tracer injection into the oculomotor and abducens nucleus
labels en grappemotor terminals and palisade endings arising
from the same parent axons
To examine whether palisade endings originate from EOM motor
nuclei, we injected the anterograde tracer BDA into either the ocul-
omotor or the abducens nucleus. These nuclei were locatedwith the
aid of the antidromic field potential elicited by electrical stimulation
applied to the IIIth and VIth nerves, respectively (Fig. 2E,F).
Following the oculomotor injections, tracer uptake involved
all subgroups of the oculomotor nucleus (Fig. 2A). In the abdu-
cens cases, tracer uptake involved the entire abducens nucleus
(Fig. 2B). Many tracer-positive axons were observed in the root-
lets of the oculomotor and abducens nerves (Fig. 2C,D).
In themuscle bellies, tracer-labeled axons and nerve terminals
were observed in the corresponding EOMs. The levator palpe-
brae superioris, which is innervated by the oculomotor nerve,
likewise contained tracer-positive axons. The number of tracer-
positive axons varied in the EOMs. In both oculomotor cases, the
inferior rectus and the medial rectus on both sides contained a
higher number of tracer-positive axons (between 36 and 73%)
than the superior rectus and the inferior oblique (between 15 and
28%). An exception was the left inferior oblique of cat 2 in which
39% of the axons contained tracer. In the abducens cases, 51–
64% of the axons were labeled in the left lateral rectus, and 31–
46% in the right lateral rectus muscle. The specific percentage of
tracer-labeled axons per EOM in each case is given in Table 2.
Combinations of BDA/anti-ChAT or alternatively BDA/-
bungarotoxin labeling showed that all tracer-positive axons en-
tering the EOMs exhibited ChAT immunoreactivity (Fig. 3A–C).
These BDA- labeled axons established -bungarotoxin-positive
motor contacts via en plaque endings on singly innervatedmuscle
fibers (SIFs) (Fig. 3D–F) and via en grappe endings onMIFs (Figs.
3G–I ). We also detected ChAT-positive axons (Fig. 3C),
-bungarotoxin-positive en plaque terminals (data not shown),
and-bungarotoxin-positive en grappemotor terminals (Fig. 3C,
arrows) that lacked tracers. Combination of BDA/anti-CGRP
showed that tracer-positive axons and en plaque and en grappe
motor endings were CGRP positive (Fig. 3J–O), like those seen in
the palisade endings (Fig. 1D–F).
Next, we examined muscle tendon transitions of EOMs to
determine whether palisade endings were anterogradely la-
beled from the oculomotor or abducens nucleus. In single
color labeling, the tracer was visualized with a DAB reaction
(Fig. 4), and in multicolor labeling, tracer visualization was
combined with immunolabeling (anti-synaptophysin, anti-
ChAT) and -bungarotoxin labeling (Fig. 5). Muscle fibers
were stained with phalloidin.
Figure 4. Three-dimensional projections of stacks of light microscopic images showing tracer-positive palisade endings, an-
terogradely labeled fromtheoculomotor nucleus, inmuscle-tendonwhole-mountpreparations. The tracerwas visualizedwith the
DAB reaction and appears in brown color. A, B, Show palisade endings in a medial rectus muscle. B, The palisade complex shown
at high magnification. C, Palisade ending in a medial rectus muscle. The tracer-positive axon supplying the palisade ending also
establishes contacts (arrows) along the muscle fiber. T, Tendon; MF, muscle fiber. Scale bars, 50m.
2788 • J. Neurosci., February 13, 2013 • 33(7):2784–2793 Zimmermann et al. • Are Palisade Endings Proprioceptive?
We found tracer-positive palisade endings exhibiting their typi-
cal morphology after both oculomotor and abducens BDA injec-
tions (Figs. 4, 5). All tracer-positive palisade endings exhibited
synaptophysin immunoreactivity (Fig. 5A–C) andChAT immuno-
reactivity as well (Fig. 5D–F). We also observed synaptophysin/
ChAT-immunoreactive palisades that contained no tracer (Fig.
5,E,F, top). An additional striking finding was that the tracer-
positive axons that formedpalisades also established en grappenerve
terminals along the muscle fibers (Fig. 4C and zfr;5Fig. 5G). These
resembled the pattern of connections found in MIFs (Fig. 1G,H).
The neuromuscular contacts bound -bungarotoxin, although the
palisade terminals did not (Fig. 5G).
In total, we counted 120 tracer-positive palisade endings, the
number varying between 1 and 13 per EOM. However, labeling
was never found in muscles not supplied by the injected nucleus.
The quantity of tracer-positive palisades for each case and each
corresponding EOM is given in Table 3. In case 2, amore detailed
count of tracer labeling was done. Specifically, tracer labeling was
combined with anti-ChAT immunostaining, and the number of
double-positive palisade endings versus the number of ChAT-
positive but tracer-negative palisade endings was counted. The
percentage of BDA-labeled palisades varied between 7 and 46%
with a mean of 26.5%.
In neither the oculomotor cases nor the abducens cases did
analyses of the trigeminal ganglion reveal tracer-positive cell bod-
ies or axons. However, in the abducens cases tracer-positive ax-
ons were observed in the abducens nerve, which passes close to
the trigeminal ganglion (Fig. 6). The oph-
thalmic, maxillary and mandibular
branches of the trigeminal nerve con-
tained no tracer. Likewise, the mesen-
cephalic trigeminal nucleus showed no
tracer labeling in the cell bodies (data not
shown).
The ophthalmic division of the
trigeminal ganglion and the ophthalmic
branch of the trigeminal nerve do not
contain cholinergic axons
To test whether cholinergic trigeminal af-
ferents supply palisade endings, immuno-
histochemical characterizations of the
trigeminal ganglion and the ophthalmic
branch of the trigeminal nerve were per-
formed. Specifically, sections of the tri-
geminal ganglion and the intracranial part
of trigeminal nervewere stainedwith anti-
ChAT and anti-neurofilament antibodies.
Immunolabeling also included the abdu-
cens nerve, which passes close to the tri-
geminal ganglion.
Within the ophthalmic division of the
trigeminal ganglion, all the perikaryawere
neurofilament-positive but ChAT-
negative (Fig. 7A–C, F). Furthermore, all
the axons of the sensory ophthalmic nerve
were neurofilament positive but lacked
ChAT immunoreactivity (Fig. 7A–D).
The sensory maxillary nerve and the sen-
sory division of the mandibular nerve
lacked ChAT immunoreactivity as well.
Exclusively, the axons belonging to the
motor fraction of the mandibular nerve
(data not shown), and those of the abducens nerve exhibited
ChAT and neurofilament immunoreactivity (Fig. 7C,E,F).
We also tested the CGRP immunoreactivity of the cat trigem-
inal ganglion. We found that the majority of trigeminal ganglion
cells were CGRP immunonegative, although some perikarya ap-
peared immunolabeled for this peptide (Fig. 7G). However, it is
important to note that such cells lacked ChAT immunoreactivity
(Fig. 7B,C,F). Axons of the nearby abducens nerve exhibited
CGRP immunoreactivity as well (Fig. 7G). In this case, the ma-
jority of motor axons (all of them ChAT immunoreactive) were
also labeled for CGRP. Nevertheless, a few axons did not exhibit
CGRP immunostaining (Fig. 7G, arrows). This finding is in
agreement with previous data in the cat abducens nucleus show-
ing that 80% of the ChAT-immunoreactive abducens mo-
toneurons are also CGRP immunopositive (Moreno-Lopez et al.,
1998; Gonza´lez-Forero et al., 2002).
Discussion
The present study represents the first combined analysis of the
molecular characteristics, innervation pattern, and source of pal-
isade endings in the cat. It indicates that palisade endings origi-
nate fromEOMnuclei, presumably fromMIFmotoneurons, and
are cholinergic and CGRP-positive. Figure 8 summarizes the
motor-like properties of palisade endings according to our
results.
Figure 5. Three-dimensional projections of stacks of CLSM images showing tracer-labeled palisade endings inmuscle-tendon,
whole-mount preparations. Tracer visualization was combined with fluorescence staining of other cellular molecules. A–C, Pali-
sade ending in a lateral rectus muscle. The visualization of the anterograde tracer BDA with streptavidin (red) was combined
anti-synaptophysin (green) and phalloidin (blue). A, A tracer-positive palisade ending. B, Palisade nerve terminals exhibit synap-
tophysin immunoreactivity. C, Overlay ofA andB. Palisade nerve terminals appear in yellowmixed color.D–F, Palisade endings in
a superior rectus muscle. Tracer visualization with avidin (green) was combined with anti-ChAT (red) and phalloidin (blue). D, A
single tracer-positive palisade ending. E, Demonstrating two ChAT-positive palisade endings. F, Overlay in yellow mixed color
exhibiting that tracer-positive palisade ending is ChAT-positive aswell. The ChAT-positive palisade ending in the upper part of the
image lacks tracer. G, Palisade ending in an inferior rectus muscle. Tracer visualization with streptavidin (red) was combinedwith
-bungarotoxin (green) and phalloidin (blue). The tracer-positive palisade ending is supplied by a nerve fiber that forms
-bungarotoxin-positive motor contacts along the muscle fiber. A detail of the motor contacts is shown in the inset. Scale
bars, 100m.
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Palisade endings have molecular characteristics of
motor terminals
Recently, it has been demonstrated in several species (cat, mon-
key, sheep, and dog) that palisade endings exhibit ChAT immu-
noreactivity (Konakci et al., 2005a; Konakci et al., 2005b;
Rungaldier et al., 2009a; Rungaldier et al., 2009b). Moreover,
palisade endings in monkeys contain choline transporter and ve-
sicular acetylcholine transporter and therefore show all the ingre-
dients for the synthesis and storage of acetylcholine, the
neurotransmitter usually found in motor terminals (Blumer et
al., 2009). Here, we confirmed that palisade endings are cholin-
ergic and have demonstrated for the first time that palisade end-
ings are also CGRP immunoreactive like motor terminals on
singly andmultiply innervatedmuscle fibers in cat EOMs. CGRP
has been detected in spinal/cranial motoneurons (Forsgren et al.,
1993;Moreno-Lo´pez et al., 1998; Gonza´lez-Forero et al., 2002) as
well as in guinea pig sensory trigeminal ganglion cells (Aigner et
al., 1997). We also observed some cells containing CGRP in the
trigeminal ganglion of cats, but these elements were noncholin-
ergic and thus cannot contribute to the formation of palisade
endings. We therefore conclude that CGRP detection in palisade
endings is more compatible with motor, as opposed to sensory,
properties (Fig. 8, see ChAT and CGRP).
Palisade endings originate from EOMmotor nuclei
The present study provided direct evidence that the source of
palisade endings lies in the EOMmotor nuclei (Fig. 8).Our quan-
titative analysis revealed that complete tracer labeling was not
obtained for all palisade endings, and the extent of tracer labeling
varied among the different EOMs. Labeling variations between
muscles likely resulted fromdifferential tracer involvement of the
oculomotor subnuclei. The lack of complete labeling in the
nerves can be explained by incomplete tracer uptake, failure of
the BDA to label the entire axon, or, alternatively, that the dura-
tion of tracer transport was not the same for all axons to all
muscles. Nevertheless, on the qualitative level our results clearly
showed that palisade endings were anterogradely labeled after
tracer injection into the EOM motor nuclei. Since all palisade
endings have the same morphology and molecular phenotype, it
is unlikely that palisade endings without tracer would differ in
their central origin.
That palisade endings have amotor origin in cats is in linewith
similar neuronal tracing experiments in monkeys (Lienbacher et
al., 2011a; Zimmermann et al., 2011), and this expansion to a
second species strongly suggests that palisade endings in mam-
mals have a common source. Evidence that palisade endings have
a motor origin also comes from an early degeneration experi-
ment. Sas and Scha´b (1952) made lesions of the oculomotor nu-
cleus in cats and found that, in addition to the expected loss of
motor endplates on the EOMs, the palisade endings degenerated.
However, in a prior cat study where neuronal tracer was injected
into the trigeminal ganglion or into the EOMmotor nuclei, only
the trigeminal ganglion injections were reported to label struc-
tures resembling palisade endings (Billig et al., 1997). Since our
tracer experiments disagreed with that previous work, we applied
an additional test. We reasoned that since palisade endings are
cholinergic structures, the trigeminal ganglion should contain
cholinergic cell bodies if trigeminal axons form palisade endings.
The present work demonstrated that this is not the case (Fig. 7).
Furthermore, the ophthalmic branch of the trigeminal nerve,
which had been supposed to carry axons of EOM proprioceptors
in various mammals, including cat, was noncholinergic and not
labeled with BDA (Manni et al., 1966; Porter and Spencer, 1982;
Porter et al., 1983). Perhaps in the previous cat study, EOMmo-
tor nerveswere contaminated by tracer due to their nearby course
(Theisen et al., 1996).
Palisade endings arise fromMIF axons
AMIFmotor fiber/palisade ending construction was observed in
25% of the cases in cats, which was similar to our previous mon-
Figure 6. CLSM images close to the trigeminal ganglion following the injection of the anterograde BDA tracer into the abducens nucleus (cat 4). Images from a single optical section show the
ophthalmic (NV1)andmaxillary (NV2)nervedivisions, aswell as theabducensnerve (NVI). A fewcell bodiesbelonging to themaxillarydivisionof the trigeminal ganglionarealso visible (arrow)A–C,
Stainingwith anti-neurofilament (red) andBDA tracer visualizationwith streptavidin (green)A,All the components are stainedby the antibody toneurofilament protein.B, Only the abducens nerve
is tracer-positive. C, Overlay of A and B showing that neurofilament/tracer-positive axons in yellowmixed color are limited to the abducens nerve. Scale bar, 100m.
Table 3. Number of tracer-positive palisade endings in different extraocular
muscles of cats 1, 2, 3, and 4 and counted number of palisade endings in cat 2
Oculomotor injections Abducens injections
EOM Cat 1a Cat 2a Cat 3a Cat 4a Cat 2b
SR le/ric 3/6 5/2 0/0 0/0 14/29
IR le/ric 5/13 4/7 0/0 0/0 20/19
LR le/ric 0/0 0/0 8/3 6/4
MR le/ric 7/10 12/13 0/0 0/0 40/57
SO le/ric 0/0 0/0 0/0 0/0
IO le/ric 2/2 7/1 0/0 0/0 15/7
Total 48 51 11 10 191
aTracer-positive palisade endings.
bAll counted.
cAbbreviations indicate the following muscles: SR, Superior rectus; IR, inferior rectus; LR, lateral rectus; MR, medial
rectus; SO, superior oblique; IO, inferior oblique; LPS, levator palpebrae superioris. Left and right are indicated as le
and ri, respectively.
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key data in which such a feature was found in 30% of the cases
(Blumer et al., 2009).Whether this innervation pattern is actually
the general scheme for palisade endings is a critical unanswered
question.
Despite their origin in the EOM motor nuclei and their con-
nection toMIF axons, it has been suggested that palisade endings
still might have a sensory function (Lienbacher et al., 2011b). In
monkeys following comparison of central and distal EOM tracer
injections, two morphologically distinct populations of retro-
gradely labeled neurons were detected in separate groups around
the periphery of the EOM motor nuclei, one multipolar and the
other consisting of round and spindle-
shaped cells. It was proposed that the lat-
ter group, which supplies the tendinous
insertion, might be similar to mesen-
cephalic trigeminal neurons, innervating
palisade endings peripherally and giving
off collaterals that terminate centrally
(Lienbacher et al., 2011b). However, there
is currently no evidence that these neu-
rons display central axon collaterals or
that the oculomotor nucleus projects to
the trigeminal sensory nuclei. The latter
would seem necessary if these cells were
the source of central sensory signals for
eye position. The present study does not
directly address the question of two types
of non-SIF efferent neurons, but the results
do not support this dichotomy. Both the
immunolabeling and tracer labeling re-
vealed axons forming palisade endings that
also established multiple nerve terminals
along the muscle fibers. Such neuromuscu-
lar contacts were undoubtedly motor, as
demonstrated by their -bungarotoxin
binding, and resembled en grappe endings
usually found onMIFs (Harker, 1972). The
only possible interpretation of the present
data is that at least some MIF motoneu-
rons supply palisade endings, as out-
lined in Figure 8.
Palisade endings share ultrastructural
features with classical proprioceptors,
but display different patterns of
molecular characteristics
Palisade endings are enigmatic structures
since, despite their clear motor character-
istics, they exhibit sensory features as well.
Specifically, palisade nerve terminals con-
tact the collagen bundles of the tendon,
which is in analogy to Golgi tendon or-
gans (Ruskell, 1978; Alvarado-Mallart
and Pinc¸on-Raymond, 1979; Richmond
et al., 1984; Blumer et al., 1998;
Rungaldier et al., 2009a). In fact, very few
palisade nerve terminals were observed
contacting the muscle fiber in sheep and
cats. When such neuromuscular contacts
were present, they lacked a basal mem-
brane. This is reminiscent of sensory
nerve terminals in muscle spindles
(Alvarado-Mallart and Pinc¸on-Raymond,
1979; Blumer et al., 1998).However, differences between palisade
endings and classical proprioceptors with respect to molecular
properties are evident. Specifically, in sheep EOMs sensory nerve
terminals in muscle spindles and Golgi tendon organs are non-
cholinergic in contrast to the cholinergic phenotype of palisade
endings (Rungaldier et al., 2009b).
The function of palisade endings is unexplained at present
Based on molecular characteristics, connectional patterns, and
innervation morphology, the present results argue that palisade
endings should not be interpreted as sensory organs (Fig. 8).
Figure 7. CLSM images from a single optical section showing branches of the trigeminal nerve [ophthalmic (NV1) and part of
themaxillary (NV2) nerve divisions], with the abducens nerve (NVI) running nearby. A few cell bodies belonging to the ophthalmic
and maxillary division of the trigeminal ganglion are also visible (arrows) A–F, Staining with anti-neurofilament (red) and anti-
ChAT (green). G, Staining with anti-neurofilament and anti-CGRP. A, Axons in the ophthalmic and maxillary nerves and their
respective perikarya exhibit neurofilament immunoreactivity, as do abducens nerve axons.B, Note that only the abducens nerve is
ChAT positive. C, Overlay ofA andB shows that only the abducens nerve contains doubly labeled axons in yellowmixed color of red
neurofilament and green ChAT. D, E, Details (white squares) captured with high magnification of the ophthalmic nerve (D) and
abducens nerve (E). The CLSM imageswere overlaidwith a light-transmitted image.F, Showing the ChAT-positive abducens nerve
(NVI) and ChAT-negative perikarya of the ophthalmic division of the trigeminal ganglion. G, In an adjacent section two CGRP-
positive perikarya in yellowmixed color of red neurofilament and green CGRP are visible. The axons of the nearby abducens nerve
(NVI) are CGRP immunoreactive as well (yellowmixed color). A few axons (arrow), however, lacked CGRP. Scale bars, 100m.
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However, a functional rationale for the
action of palisade endings is difficult to
find. Upon excitation, neurotendinous
contacts in palisade endings presumably
release acetylcholine, but it remains un-
clear what effect, if any, neurotransmitter
release would have on collagen fibrils.
Maybe receptors for acetylcholine are
present at the muscle fiber tip, either at
very low densities (undetectable by the
-bungarotoxin staining) or as yet un-
identified receptor proteins. Thus, when a
MIF motoneuron forming palisade end-
ings fires, palisade endings would allow
muscle fiber contraction just at the termi-
nal part of the muscle fiber, while en
grappe endings would elicit contraction of
the muscle fiber body. Contraction just at
the fiber endwould create only smallmus-
cle forces, but this may be necessary for
the fine alignment of gaze or to maintain
extreme eye positions.
An eye position signal has been identi-
fied in the primary somatosensory cortex
of monkey (Wang et al., 2007), and loss of sensory input to the
orbit can affect oculomotor and other behaviors (Fiorentini et al.,
1986; Knox et al., 2000) even though classical proprioceptors are
nearly absent. Moreover, when palisade endings are damaged
following strabismus surgery, patients exhibit deficits in spatial
perception (Steinbach and Smith, 1981; Steinbach et al., 1987).
These data suggest that eye muscles must have some type of sen-
sory receptors. Possibly information from nonspecialized recep-
tors, like those reported by Billig et al. (1997), enters the brain
through conventional trigeminal pathways (Porter and Donaldson,
1991) and is combinedwith information on the pulling direction of
the innervatedmuscles to produce the eye position signals recorded
in the somatosensory cortexandelsewhere (Donaldson,2000;Wang
et al., 2007;). The need for a muscle spindle in an EOM that always
experiences the same load is unclear, so a less specialized sensory
systemmay be sufficient.
The present study complements our prior immunohisto-
chemical findings and does not support the hypothesis that pal-
isade endings are sensory proprioceptive organs. Clearly,
physiological and cell biological investigation of palisade endings
is imperative to identify their function.
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